Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Angelin

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|April 2, 2016
Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief ReportJohanna Apro, Uwe J F Tietge, Arne Dikkers, et al.
Endocrinology|July 31, 2004
Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult ratsAnne-Maj Samuelsson, Iris Ohrn, Jovanna Dahlgren, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2002
Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiencyCecilia Gälman, Ann-Margret Ostlund-Lindqvist, Anna Björquist, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liverMats Rudling, Bo Angelin, Lars Ståhle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid miceLisen Johansson, Mats Rudling, Thomas S Scanlan, et al.
JCI Insight|April 7, 2026
Increased transvascular retention of atherogenic lipoproteins in type 2 diabetes relates to their enhanced proteoglycan-bindingPär Björklund, Jennifer Härdfeldt, Lauri Äikäs, et al.
Atherosclerosis|January 14, 2024
Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemiaTigist Wodaje, Ali Mahdi, Ashwin Venkateshvaran, et al.
Molecular and Cellular Endocrinology|December 8, 2019
Selective estrogen receptor (ER)β activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male miceMarcela González-Granillo, Christina Savva, Xidan Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 6, 2003
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humansSuzanne Lind, Mats Rudling, Sverker Ericsson, et al.
Biochemical and Biophysical Research Communications|July 3, 2007
PPARalpha is a key regulator of hepatic FGF21Thomas Lundåsen, Mary C Hunt, Lisa-Mari Nilsson, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Arteriosclerosis, Thrombosis, and Vascular Biology|April 2, 2016
Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus-Brief ReportJohanna Apro, Uwe J F Tietge, Arne Dikkers, et al.
Endocrinology|July 31, 2004
Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult ratsAnne-Maj Samuelsson, Iris Ohrn, Jovanna Dahlgren, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2002
Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiencyCecilia Gälman, Ann-Margret Ostlund-Lindqvist, Anna Björquist, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Regulation of hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and cholesterol 7alpha-hydroxylase mRNAs in human liverMats Rudling, Bo Angelin, Lars Ståhle, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2005
Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid miceLisen Johansson, Mats Rudling, Thomas S Scanlan, et al.
JCI Insight|April 7, 2026
Increased transvascular retention of atherogenic lipoproteins in type 2 diabetes relates to their enhanced proteoglycan-bindingPär Björklund, Jennifer Härdfeldt, Lauri Äikäs, et al.
Atherosclerosis|January 14, 2024
Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemiaTigist Wodaje, Ali Mahdi, Ashwin Venkateshvaran, et al.
Molecular and Cellular Endocrinology|December 8, 2019
Selective estrogen receptor (ER)β activation provokes a redistribution of fat mass and modifies hepatic triglyceride composition in obese male miceMarcela González-Granillo, Christina Savva, Xidan Li, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 6, 2003
Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humansSuzanne Lind, Mats Rudling, Sverker Ericsson, et al.
Biochemical and Biophysical Research Communications|July 3, 2007
PPARalpha is a key regulator of hepatic FGF21Thomas Lundåsen, Mary C Hunt, Lisa-Mari Nilsson, et al.
Pageof 7